Advertisement
DHR vs MTD
Which Stock Would AI Choose? Danaher (DHR) vs. Mettler-Toledo (MTD) Stock Comparison
Key Takeaways
- DHR and MTD operate in overlapping life sciences and precision instruments sectors, offering investors exposure to analytical and diagnostic technologies.
- DHR recently completed the Masimo acquisition and beat Q1 2026 earnings estimates, with Q2 results scheduled for July 21.
- MTD reported solid Q1 2026 growth with sales up 7% and adjusted EPS up 9%, though it faces margin pressures and was removed from the Russell 1000 index.
- DHR trades near $204 while MTD trades near $1,310 as of mid-July 2026, reflecting different market capitalizations and volatility profiles.
- Both companies have upcoming quarterly earnings that could influence near-term sentiment, with DHR showing more acquisition-driven momentum in recent weeks.
- Relative performance highlights trade-offs between DHR’s broader diversification and MTD’s specialized high-margin product focus.
Introduction
This comparison examines DHR (Danaher Corporation) and MTD (Mettler-Toledo International Inc.), two established players in the life sciences and precision measurement industries. Both companies supply instruments and solutions used in research, diagnostics, and industrial applications, making them relevant for investors seeking exposure to healthcare technology and laboratory equipment trends. Portfolio managers, sector-focused traders, and those evaluating relative value within the broader healthcare equipment space may find the analysis useful for assessing business model differences, recent momentum, and positioning amid evolving market conditions.
DHR Overview and Recent Performance
Danaher Corporation provides a diversified portfolio of life sciences, diagnostics, and environmental solutions through brands focused on analytical instruments and bioprocessing. In recent market activity, the stock has reflected optimism tied to the completed Masimo acquisition and a strong Q1 2026 earnings beat, where adjusted EPS rose 9.5% to $2.06. Revenue increased 3.5% year-over-year to $6.0 billion. The company maintains a quarterly dividend of $0.40 per share. As of July 17, 2026, shares closed near $203.83. Upcoming Q2 2026 results on July 21 are expected to provide further insight into integration progress and end-market demand, supporting a generally stable sentiment in recent weeks despite broader sector pressures.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. specializes in precision instruments, including laboratory balances, analytical systems, and industrial weighing solutions. The company reported Q1 2026 results with sales of $947.1 million, up 7% from the prior year, and adjusted EPS of $8.91, up 9%. In recent market activity, shares have experienced volatility, closing at $1,310.02 on July 17, 2026, amid margin pressures and the company’s removal from the Russell 1000 index. Q2 2026 earnings are scheduled for July 30. Performance over recent weeks has been influenced by these operational factors and mixed year-to-date returns, with the stock down approximately 6% from the start of 2026 while maintaining a 52-week range between roughly $1,023 and $1,525.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of the platform’s AI trading bots. Tickeron offers hundreds of AI trading bots that trade thousands of different tickers across various markets. Only the best-performing and most suitable bots for prevailing market conditions earn placement in this trending section. Available bots feature a wide range of trading styles, strategies, timeframes, performance metrics, and ticker sets, allowing users to explore options aligned with different risk tolerances and objectives. Statistics such as win rates, profit factors, and drawdowns vary by bot and are updated regularly to reflect live results. For traders interested in automated strategies, reviewing the Trending AI Robots page provides an accessible starting point.
Head-to-Head Comparison
DHR operates a broader business model spanning diagnostics, life sciences, and environmental solutions, while MTD concentrates on high-precision analytical and weighing instruments, resulting in differing exposure to end markets and acquisition-driven growth. Recent momentum favors DHR following its Masimo deal and earnings outperformance, contrasted with MTD’s solid but pressured Q1 results and index removal. Risk factors include integration challenges for DHR versus margin compression for MTD. Sector exposure overlaps in laboratory and research applications, yet DHR offers greater diversification while MTD provides deeper specialization. Market sentiment reflects cautious optimism for both ahead of earnings, with DHR appearing more resilient in recent trading periods.
Tickeron AI Verdict
Based on observable factors such as trend consistency following the recent acquisition, earnings stability, and relative positioning ahead of the July 21 report, Tickeron’s AI models would currently assign a modestly higher probability of favorable near-term performance to DHR compared with MTD. This assessment draws from acquisition-related catalysts and a stronger recent earnings track record, though outcomes remain subject to actual results and broader market dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Hold and MTD is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 1 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).
- DHR’s FA Score: 1 green, 4 red.
- MTD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 4 TA indicator(s) are bullish while MTD’s TA Score has 5 bullish TA indicator(s).
- DHR’s TA Score: 4 bullish, 5 bearish.
- MTD’s TA Score: 5 bullish, 5 bearish.
Price Growth
DHR (@Medical Specialties) experienced а -6.05% price change this week, while MTD (@Medical Specialties) price change was +1.31% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.55%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +1.12%.
Reported Earning Dates
DHR is expected to report earnings on Oct 27, 2026.
MTD is expected to report earnings on Jul 30, 2026.
Industries' Descriptions
@Medical Specialties (-1.55% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| DHR | MTD | DHR / MTD | |
| Capitalization | 135B | 26.8B | 504% |
| EBITDA | 7.08B | 1.25B | 564% |
| Gain YTD | -15.994 | -4.806 | 333% |
| P/E Ratio | 34.14 | 31.18 | 109% |
| Revenue | 24.8B | 4.09B | 606% |
| Total Cash | N/A | 60.6M | - |
| Total Debt | 18.5B | 2.23B | 830% |
DHR | MTD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 2 | |
PRICE GROWTH RATING 1..100 | 51 | 46 | |
P/E GROWTH RATING 1..100 | 72 | 51 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DHR's Valuation (6) in the Medical Specialties industry is significantly better than the same rating for MTD (99). This means that DHR’s stock grew significantly faster than MTD’s over the last 12 months.
DHR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MTD (100). This means that DHR’s stock grew similarly to MTD’s over the last 12 months.
MTD's SMR Rating (2) in the Medical Specialties industry is significantly better than the same rating for DHR (80). This means that MTD’s stock grew significantly faster than DHR’s over the last 12 months.
MTD's Price Growth Rating (46) in the Medical Specialties industry is in the same range as DHR (51). This means that MTD’s stock grew similarly to DHR’s over the last 12 months.
MTD's P/E Growth Rating (51) in the Medical Specialties industry is in the same range as DHR (72). This means that MTD’s stock grew similarly to DHR’s over the last 12 months.
| DHR | MTD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 46% | 2 days ago 67% |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 66% |
| MACD ODDS (%) | 2 days ago 70% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 53% | 2 days ago 58% |
| Advances ODDS (%) | 3 days ago 54% | 10 days ago 60% |
| Declines ODDS (%) | 5 days ago 61% | 6 days ago 66% |
| BollingerBands ODDS (%) | 2 days ago 57% | 2 days ago 86% |
| Aroon ODDS (%) | 2 days ago 54% | 2 days ago 53% |
Advertisement
DHR and
Correlation & Price change
A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | -0.35% | ||
| A - MTD | 71% Closely correlated | -0.84% | ||
| TMO - MTD | 68% Closely correlated | -0.71% | ||
| BRKR - MTD | 67% Closely correlated | -2.74% | ||
| DHR - MTD | 64% Loosely correlated | -0.52% | ||
| AZTA - MTD | 61% Loosely correlated | -3.29% | ||
More | ||||